Overview

Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects

Status:
Completed
Trial end date:
2018-03-09
Target enrollment:
Participant gender:
Summary
This study will be conducted to demonstrate the bioequivalence between a single 4 milligram (mg) dose of fine granules of perampanel and a single 4 mg tablet of perampanel.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Co., Ltd.